Ping Qu Selected Research

Neoplasms (Cancer)

12/2019	Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.
9/2019	Huaier extract enhances the treatment efficacy of imatinib in Ik6+ Ph+ acute lymphoblastic leukemia.
10/2018	P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.
1/2017	Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
10/2016	Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.
2/2016	Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder.
2/2015	microRNA‑99a inhibits cell proliferation, colony formation ability, migration and invasion by targeting fibroblast growth factor receptor 3 in prostate cancer.
12/2014	Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
2/2013	Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis.
1/2013	Knockdown of regulator of cullins-1 (ROC1) expression induces bladder cancer cell cycle arrest at the G2 phase and senescence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Qu Research Topics

Disease

25	Neoplasms (Cancer) 12/2019 - 04/2002
9	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022 - 01/2013
6	Carcinogenesis 01/2017 - 04/2002
6	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 06/2003
5	Carcinoma (Carcinomatosis) 02/2016 - 06/2003
5	Breast Neoplasms (Breast Cancer) 07/2004 - 04/2002
4	Phenylketonurias (Phenylketonuria) 04/2024 - 10/2023
4	Obesity 10/2023 - 01/2016
4	Vitamin A Deficiency 06/2012 - 01/2006
3	Hypertension (High Blood Pressure) 05/2023 - 01/2018
3	Insulin Resistance 07/2022 - 12/2008
3	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 08/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2015 - 09/2010
3	Hypoxia (Hypoxemia) 05/2015 - 09/2008
3	Transitional Cell Carcinoma 03/2015 - 01/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 02/2004
2	Body Weight (Weight, Body) 10/2023 - 10/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 01/2022
2	Adenocarcinoma of Lung 05/2023 - 10/2005
2	Stroke (Strokes) 01/2023 - 09/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 09/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 02/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 11/2015
2	Fibrosis (Cirrhosis) 05/2015 - 01/2015
2	Ischemia 11/2013 - 09/2008
2	Anemia 01/2012 - 11/2009
2	Melanoma (Melanoma, Malignant) 05/2010 - 09/2005
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2008 - 10/2008
2	Esophageal Neoplasms (Esophageal Cancer) 06/2003 - 04/2002
1	Mucopolysaccharidoses 04/2024
1	Tyrosinemias (Tyrosinemia) 04/2024
1	Hypercholesterolemia 05/2023
1	Hemiplegia (Spastic Hemiplegia) 01/2023
1	Abdominal Obesity 01/2023
1	Cerebral Infarction 09/2022
1	Necrosis 09/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2022
1	Hyperplasia 01/2022
1	Gestational Weight Gain 01/2022
1	Neointima 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 05/2016 - 04/2002
8	Vitamin A (Retinol)FDA LinkGeneric 01/2022 - 01/2006
8	LuciferasesIBA 05/2016 - 03/2013
7	AntigensIBA 05/2010 - 06/2003
6	Messenger RNA (mRNA)IBA 10/2023 - 03/2005
4	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 04/2024 - 10/2023
4	Insulin (Novolin)FDA Link 07/2022 - 10/2008
4	Small Interfering RNA (siRNA)IBA 01/2017 - 10/2005
4	Biomarkers (Surrogate Marker)IBA 10/2015 - 04/2002
4	VaccinesIBA 07/2008 - 01/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 05/2015
3	CytokinesIBA 09/2022 - 02/2013
3	Therapeutic UsesIBA 01/2022 - 05/2010
3	MicroRNAs (MicroRNA)IBA 10/2016 - 06/2014
3	EnzymesIBA 10/2015 - 02/2013
3	Cancer VaccinesIBA 05/2010 - 01/2004
3	Peptides (Polypeptides)IBA 07/2008 - 08/2004
3	EpitopesIBA 07/2008 - 06/2003
3	SuperantigensIBA 08/2006 - 01/2004
2	Phenylalanine (L-Phenylalanine)FDA Link 10/2023 - 10/2023
2	LipidsIBA 10/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 10/2023 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2023
2	Metalloproteases (Metalloproteinases)IBA 11/2022 - 03/2013
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2022
2	huaierIBA 10/2020 - 09/2019
2	Monoclonal AntibodiesIBA 10/2015 - 04/2002
2	ImmunosorbentsIBA 10/2015 - 02/2013
2	CollagenIBA 05/2015 - 09/2010
2	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2015 - 09/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2015 - 01/2015
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 02/2015 - 04/2014
2	Matrix Metalloproteinase 13IBA 08/2013 - 03/2013
2	MicronutrientsIBA 01/2012 - 11/2009
2	eel ventricular natriuretic peptideIBA 09/2010 - 01/2010
2	DNA VaccinesIBA 05/2010 - 09/2004
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2008 - 10/2008
2	Insulin Receptor Substrate ProteinsIBA 12/2008 - 10/2008
2	Insulin ReceptorIBA 12/2008 - 10/2008
2	retinoic acid receptor betaIBA 03/2005 - 04/2002
2	Caspase 3 (Caspase-3)IBA 01/2004 - 04/2003
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 04/2024
1	Iduronidase (alpha-L-Iduronidase)IBA 04/2024
1	antineoplaston A10 (A 10)IBA 10/2023
1	Particulate MatterIBA 05/2023
1	Interleukin-17 (Interleukin 17)IBA 09/2022
1	CopperIBA 01/2022
1	anemoside B4IBA 01/2022
1	AcyltransferasesIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	GlycolipidsIBA 01/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2020
1	Vincristine (Oncovin)FDA LinkGeneric 10/2020

Therapy/Procedure

4	Immunotherapy 05/2023 - 06/2003
4	Therapeutics 05/2023 - 10/2013